| 英文名称 | 中文名称 | CAS | MF |
|
4-{[(E)-1H-indol-3-ylmethylidene]amino}benzamide
|
|
|
C16H13N3O
|
|
3-{[(E)-1H-indol-3-ylmethylidene]amino}benzonitrile
|
|
|
C16H11N3
|
|
2-[(E)-1H-indol-3-ylmethylidene]-N-(3-methylphenyl)-1-hydrazinecarbothioamide
|
|
|
C17H16N4S
|
|
2-[(E)-1H-indol-3-ylmethylidene]-N-phenyl-1-hydrazinecarboxamide
|
|
|
C16H14N4O
|
|
(2-{[(E)-1H-indol-3-ylmethylidene]amino}phenyl)(phenyl)methanone
|
|
|
C22H16N2O
|
|
2-{[(E)-1H-indol-3-ylmethylidene]amino}benzonitrile
|
|
|
C16H11N3
|
|
2-{[(E)-1H-indol-3-ylmethylidene]amino}-5-methylphenol
|
|
|
C16H14N2O
|
|
1-{[(E)-1H-indol-3-ylmethylidene]amino}-4,6-dimethyl-2(1H)-pyridinone
|
|
|
C16H15N3O
|
|
4-{[(E)-1H-indol-3-ylmethylidene]amino}benzenesulfonamide
|
|
83088-98-6
|
C15H13N3O2S
|
|
(E)-5-((2-(1H-Indol-3-yl)ethylimino)(phenyl)methyl)-1,3-diphenylpyrimidine-2,4,6(1H,3H,5H)-trione
|
|
|
C33H26N4O3
|
|
(E)-5-((2-(1H-Indol-3-yl)ethylimino)(4-fluorophenyl)methyl)-1,3-diphenylpyrimidine-2,4,6(1H,3H,5H)-trione
|
|
|
C33H25FN4O3
|
|
(5E)-5-(1H-indol-3-ylmethylidene)-2-methyl-3-[5-[2-[(2-methylphenyl)am ino]acetyl]sulfanyl-1,3,4-thiadiazol-2-yl]imidazol-4-one
|
|
127227-38-7
|
C24H20N6O2S2
|
|
(5E)-5-(1H-indol-3-ylmethylidene)-2-methyl-3-[5-[2-[(3-nitrophenyl)ami no]acetyl]sulfanyl-1,3,4-thiadiazol-2-yl]imidazol-4-one
|
|
127227-41-2
|
C23H17N7O4S2
|
|
(5E)-5-(1H-indol-3-ylmethylidene)-3-[5-[2-[(4-methoxyphenyl)amino]acet yl]sulfanyl-1,3,4-thiadiazol-2-yl]-2-methyl-imidazol-4-one
|
|
127227-42-3
|
C24H20N6O3S2
|
|
(1E)-1H-Indene-1,3(2H)-dione [(2E)-3-allyl-4-(4-methoxyphenyl)-1,3-thiazol-2(3H)-ylidene]hydrazone
|
|
|
C22H19N3O2S
|
|
(E)-4-(1H-Indol-3-yl)-but-3-en-2-one
|
|
|
C12H11NO
|
|
(E)-3-(1-(3-(2-(1H-Indol-3-yl)ethylamino)-2-hydroxypropyl)-1H-indol-3-yl)-1-(4-bromophenyl)prop-2-en-1-one
|
|
|
C30H28BrN3O2
|
|
(E)-3-(1-(3-(2-(1H-Indol-3-yl)ethylamino)-2-hydroxypropyl)-1H-indol-3-yl)-1-phenylprop-2-en-1-one
|
|
|
C30H29N3O2
|
|
5-[(E)-{[2-(1H-Indol-3-yl)ethyl]amino}(phenyl)methylidene]-1-(4-methoxyphenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
|
|
|
C28H24N4O4
|
|
(3E)-1H-Indole-2,3-dione 3-[N-(tetrahydrofuran-2-ylmethyl)thiosemicarbazone]
|
3-[(2-氧代-2,3-二氢-1H-吲哚-3-亚基)胺]-1-(氧杂环戊烷-2-基甲基)硫脲
|
519152-97-7
|
C14H16N4O2S
|
|
(E)-5-((2-(1H-Indol-3-yl)ethylamino)(4-methoxyphenyl)methylene)-1-(4-bromophenyl)pyrimidine-2,4,6(1H,3H,5H)-trione
|
|
|
C28H23BrN4O4
|
|
(E)-5-((2-(1H-Indol-3-yl)ethylamino)(phenyl)methylene)-1-(4-bromophenyl)pyrimidine-2,4,6(1H,3H,5H)-trione
|
|
|
C27H21BrN4O3
|
|
2-[(E)-2-(1H-Indol-3-yl)vinyl]-3-(2-methylphenyl)quinazolin-4(3H)-one
|
|
|
C25H19N3O
|
|
(E)-2-(3-(2-(1H-Indol-3-yl)ethyl)-4-oxo-2-(phenylimino)thiazolidin-5-yl)-N-phenylacetamide
|
|
|
C27H24N4O2S
|
|
(E)-5-((2-(1H-Indol-3-yl)ethylamino)(4-chlorophenyl)methylene)-1-(4-methoxyphenyl)pyrimidine-2,4,6(1H,3H,5H)-trione
|
|
|
C28H23ClN4O4
|
|
(E)-5-((2-(1H-Indol-3-yl)ethylimino)(p-tolyl)methyl)-1,3-diphenylpyrimidine-2,4,6(1H,3H,5H)-trione
|
|
|
C34H28N4O3
|
|
(5E)-5-(1H-Indol-3-ylmethylene)-3-(4-methoxyphenyl)-2-thioxo-1,3-thiazolidin-4-one
|
|
|
C19H14N2O2S2
|
|
(E)-2-(3-(2-(1H-Indol-3-yl)ethyl)-2-(2-chlorophenylimino)-4-oxothiazolidin-5-yl)-N-phenylacetamide
|
|
|
C27H23ClN4O2S
|
|
(E)-5-((2-(1H-Indol-3-yl)ethylamino)(4-chlorophenyl)methylene)-1-(4-bromophenyl)pyrimidine-2,4,6(1H,3H,5H)-trione
|
|
|
C27H20BrClN4O3
|
|
4-[(E)-2-(1H-Indol-3-yl)-vinyl]-1-methyl-pyridinium
|
|
692717-80-9
|
C16H15N2+
|
|
(E)-3-(1H-Indol-2-yl)acrylaldehyde
|
|
|
C11H9NO
|
|
3-[(E)-3-(1H-Indol-7-yl)-1,1-dimethyl-2-propenyl]-7-(3-methyl-2-butenyl)-1H-indole
|
|
99102-32-6
|
C26H28N2
|
|
(5E)-5-(1H-Indol-3-ylmethylene)-2-thioxo-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidin-4-one
|
|
|
C19H11F3N2OS2
|
|
(E)-5-((1H-Indol-3-yl)methylene)-3-(2-oxo-2-(4-phenylpiperazin-1-yl)ethyl)thiazolidine-2,4-dione
|
|
|
C24H22N4O3S
|
|
2-[(E)-2-(1H-Indol-3-yl)vinyl]quinazolin-4(3H)-one
|
|
|
C18H13N3O
|
|
(E)-3-(1H-indol-4-yl)acrylic acid
|
|
103573-69-9
|
C11H9NO2
|
|
(E)-3-(1H-indol-7-yl)acrylic acid
|
3-(1H-吲哚-7-基)丙酸
|
288371-43-7
|
C11H9NO2
|
|
(E)-1-((2-(1H-Indol-3-yl)ethylamino)(4,6-dimethylpyrimidin-2-ylamino)methylene)-3-(4-nitrophenyl)urea
|
|
|
C24H24N8O3
|
|
5-[(E)-1H-indol-3-ylmethylidene]-2-thioxotetrahydro-4H-imidazol-4-one
|
|
|
C12H9N3OS
|
|
(E)-5-((2-(1H-Indol-3-yl)ethylimino)(4-methoxyphenyl)methyl)-1,3-diphenylpyrimidine-2,4,6(1H,3H,5H)-trione
|
|
|
C34H28N4O4
|
|
5-[(E)-{[2-(1H-Indol-3-yl)ethyl]amino}(phenyl)methylidene]-1-(2-methylphenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
|
|
|
C28H24N4O3
|
|
2-[(E)-2-(1H-Indol-3-yl)vinyl]-3-(4-methoxyphenyl)quinazolin-4(3H)-one
|
|
|
C25H19N3O2
|
|
(E)-5-((2-(1H-Indol-3-yl)ethylimino)(4-chlorophenyl)methyl)-1,3-diphenylpyrimidine-2,4,6(1H,3H,5H)-trione
|
|
|
C33H25ClN4O3
|
|
[(5E)-5-(1H-Indol-3-ylmethylene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid
|
|
|
C14H10N2O3S2
|
|
EGTIKGGEMKNCSFNITTSI
|
|
|
C89H148N24O32S2
|
|
E. Histolytica (Amebiasis) ELISA
|
阿米巴
|
|
|
|
Egualen
|
乙呱仑
|
99287-30-6
|
C15H18O3S
|
|
EIA Antiserum Dye
|
|
|
|
|
EIA Buffer Concentrate (10X)
|
|
|
|
|
EHK2/FC CHIMERA
|
EHK2/FC CHIMERA
|
|
|
|
EGT2 protein
|
|
|
|
|
EHK1 ligand
|
|
|
|
|
EG-VEGF Polyclonal Ab
|
|
|
|
|
EG-VEGF, HUMAN
|
EG-VEGF, HUMAN
|
|
|
|
ehk-1 protein
|
|
|
|
|
Ehk-3 protein
|
|
|
|
|
ehk-2 protein
|
|
|
|
|
EGUSSI
|
|
|
|
|
EIA Tracer Dye
|
|
|
|
|
Eicanosyltrimethylammonium bromide
|
|
|
C23H50BrN
|
|
(E)-2-(2H3)Methyl-(1,1,1-2H3)-6-octen-2-ol tosylate
|
|
|
|
|
(5E)-5-(2H3)Methyl-5-tridecene
|
|
|
|
|
EGVPSTAIREISLLKE
|
|
|
C76H132N20O26
|
|
EGX254
|
|
|
|
|
Ehna hydrochloride
|
EHNA HYDROCHLORIDE
|
51350-19-7
|
C14H23N5O
|
|
2-[(E)-4-[2H-Naphtho[1,2-d]triazol-2-yl]styryl]benzoxazole
|
|
|
C25H16N4O
|
|
9-Eicocyl-10-phosphabicyclononane [3.3.1]
|
|
|
|
|
9-Eicocyl-10-phosphabicyclononane [4.2.1]
|
|
|
|
|
eiconol
|
|
|
|
|
Eicosadienoic acid (8Z,14Z)
|
EICOSADIENOIC ACID (8Z,14Z)
|
135498-07-6
|
C20H36O2
|
|
Eicosadienoic acid (5Z,14Z)
|
EICOSADIENOIC ACID (5Z,14Z)
|
122055-58-7
|
C20H36O2
|
|
Eicosapentaenoic Acid-d5 Ethyl Ester
|
EICOSAPENTAENOIC ACID-D5 ETHYL ESTER
|
|
C22H34O2
|
|
Eicosanoic acid tryptamide
|
|
152766-92-2
|
C30H50N2O
|
|
2-Eicosapentaenoyl-sn-glycerol-3-phosphocholine
|
|
112667-21-7
|
C28H48NO7P
|
|
1-Eicosapentaenoyl-sn-glycerol-3-phosphocholine
|
胆碱杂质5
|
162440-04-2
|
C28H48NO7P
|
|
Eicosapentaenoic SphingoMyelin
|
|
|
C43H77N2O6P
|
|
1-Eicosanol (Arachidyl Alcohol)
|
|
|
|
|
11-Eicosenoic acid methyl ester
|
|
|
C21H40O2
|
|
Eicosanoic acid-20,20,20-D3
|
|
|
C20H37D3O2
|
|
Eicosanoic acid-D39
|
|
|
C20HD39O2
|
|
Eicosanoic acid-2,2-D2
|
|
|
C20H38D2O2
|
|
Eicosanoic acid-D40
|
|
|
C20D40O2
|
|
8,11,14-Eicosatriynoic Acid
|
8,11,14-Eicosatriynoic Acid
|
34262-64-1
|
C20H28O2
|
|
Eicosapentaenoic Acid Quant-PAK
|
|
|
|
|
Eicosapentaenoyl Ethanolamide
|
Eicosapentaenoyl Ethanolamide
|
109001-03-8
|
C22H35NO2
|
|
Eicosapentaenoyl Serotonin
|
Eicosapentaenoyl Serotonin
|
199875-71-3
|
C30H40N2O2
|
|
Eicosanoid Affinity Column Elution Solution
|
|
|
|
|
Eicosanoid Affinity Column Buffer (5X)
|
Eicosanoid Affinity Column Buffer (5X)
|
|
|
|
9-(Eicosan-11-yl)-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole
|
9,9-二癸基芴-2,7-二硼酸二频哪醇酯
|
1185885-88-4
|
C45H73B2NO4
|
|
Eicosanyl caffeate
|
3-(3,4-二羟基苯基)-2-丙烯酸二十烷基酯
|
905726-67-2
|
C29H48O4
|
|
eicosa-5,11,14-trienoic acid
|
|
15541-36-3
|
C20H34O2
|
|
Eicosanoic acid-1-13C 99%
|
|
|
C20H40O2
|
|
1-Eicosene
|
1-二十烯
|
3452-07-1
|
C20H40
|
|
Eicosapentaenoic acid ethyl ester(EPA ee)(RG)
|
二十五碳烯酸乙酯
|
|
|
|
Eicosatetraenoic acid 8,11,14,17
|
|
|
C20H32O2
|
|
1,7,13,19-Eicosatetrayne
|
|
872-27-5
|
C20H26
|
|
8,11-Eicosadiynoic acid [1-14C]
|
|
|
C20H32O2
|
|
Eicosapentaenoic acid ethyl ester(EPA ee)(reagent / standard grade)
|
|
|
|
|
Eicosatrienoic acid, 11,14,17-[1-14C]
|
|
|
|
|
Eicosapentaenoic acid(epa)(reagent / standard grade)
|
|
|
|